A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery

Journal of Clinical Anesthesia

Volumn 17, Issue 6, 2005, Pages 439-443

  Kim, Jung T ^a   Sherman, Orrin ^b   Cuff, Germaine ^a   Leibovits, Allen ^a   Wajda, Michael ^a   Bekker, Alex Y ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ketorolac; Postoperative pain; Rofecoxib

Indexed keywords

ANALGESIC AGENT; KETOROLAC; OXYCODONE; PARACETAMOL; PLACEBO; ROFECOXIB;

ADULT; ANALGESIC ACTIVITY; ARTHROSCOPIC SURGERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; KNEE ARTHROSCOPY; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TIME SERIES ANALYSIS;

ADULT; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROSCOPY; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HUMANS; KETOROLAC; KNEE; KNEE INJURIES; LACTONES; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SULFONES;

EID: 24944472217     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2004.09.008     Document Type: Article

References (21)

1. H. Kehlet, G.W. Rung, and T. Callesen Postoperative opioid analgesia: time for a reconsideration? J Clin Anesth 8 1996 441 445
2. A. Blackburn, J.D. Stevens, R.G. Wheatley, T.H. Madej, and D. Hunter Balanced analgesia with intravenous ketorolac and patient-controlled morphine following lower abdominal surgery J Clin Anesth 7 1995 103 108
3. B.L. Strom, J.A. Berlin, and J.L. Kinman Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study JAMA 275 1996 376 382
4. I. Gilron, B. Milne, and M. Hong Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions Anesthesiology 99 2003 1198 1208
5. S. Reuben, S. Bhopatkar, H. Maciolek, W. Joshi, and J. Sklar The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery Anesth Analg 94 2002 55 59
6. M.F. Watcha, T. Issioui, K.W. Klein, and P.F. White Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery Anesth Analg 96 2003 987 994
7. P.F. White The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery Anesth Analg 94 2002 577 585
8. A. Bekker, P.R. Cooper, A. Frempong-Boadu, R. Babu, T. Errico, and A. Lebovits Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery Neurosurgery 50 2002 1053 1057
9. S.S. Reuben, N.R. Connelly, and R. Steinberg Ketorolac as an adjunct to patient-controlled morphine in postoperative spine surgery patients Reg Anesth 22 1997 343 346
10. J.B. Dahl, and H. Kehlet Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain Br J Anaesth 66 1991 703 712
11. C.J. Hawkey COX-2 inhibitors Lancet 353 1999 307 314
12. P.A. Wolfe, C.D. Polhamus, C. Kubic, A.B. Robinson, and D.J. Clement Giant duodenal ulcers associated with the postoperative use of ketorolac: report of three cases Am J Gastroenterol 89 1994 1110 1111
13. T.L. Yarboro Intramuscular toradol: gastrointestinal bleeding, and peptic ulcer perforation: a case report J Natl Med Assoc 87 1995 225 227
14. L. Haragsim, R. Datal, H. Bagga, and B. Bastani Ketorolac-induced acute renal failure and hyperkalemia: report of three cases Am J Kidney Dis 24 1994 578 580
15. K. Smith, R.M. Halliwell, S. Lawrence, P.L. Klineberg, and P. O'Connell Acute renal failure associated with intramuscular ketorolac Anaesth Intensive Care 21 1993 700 702
16. N.M. Gajraj Cyclooxygenase-2 inhibitors Anesth Analg 96 2003 1720 1738
17. N.M. Davies, X.W. Teng, and N.M. Skjodt Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor Clin Pharmacokinet 42 2003 545 556
18. S.A. Strassels, C. Chen, and D.B. Carr Postoperative analgesia: economics, resource use, and patient satisfaction in an urban teaching hospital Anesth Analg 94 2002 130 137
19. M. Afilalo, and C. Tselios Pain relief versus patient satisfaction Ann Emerg Med 27 1996 436 438
20. J.A. Lewis, B. Jonsson, G. Kreutz, C. Sampaio, and B. van Zwieten-Boot Placebo-controlled trials and the declaration of Helsinki Lancet 359 2002 1337 1340
21. R. Temple, and S.S. Ellenberg Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues Ann Intern Med 133 2000 455 463